A detailed history of Cibc Private Wealth Group, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,825 shares of AKBA stock, worth $5,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,825
Previous 100 2725.0%
Holding current value
$5,198
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.94 - $1.55 $2,561 - $4,223
2,725 Added 2725.0%
2,825 $3,000
Q1 2024

May 10, 2024

BUY
$1.27 - $2.24 $127 - $224
100 New
100 $0

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $338M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.